FIELD: pharmacology.
SUBSTANCE: method and a kit for prediction of a high likelihood of a positive effect of treatment with VEGF antagonists in a patient with metastatic breast cancer, where this effect is determined in a patient with VEGF genotype (-1154AA), are proposed.
EFFECT: effective means and methods for prediction of the high likelihood of a positive effect of treatment with VEGF antagonists in a patient with metastatic breast cancer.
5 cl, 5 tbl, 1 ex
| Title |
Year |
Author |
Number |
| VEGF POLYMORPHISM AND ANTIANGIOGENESIS THERAPY |
2008 |
- Shnajder Brajan P.
- Radovich Milan
- Sledzh Dzhordzh U.
|
RU2482491C2 |
| GENETIC POLYMORPHISMS IN AGE-RELATED MACULAR DEGENERATION |
2010 |
|
RU2577726C2 |
| GENETIC POLYMORPHISMS ACCOMPANYING AGE-RELATED MACULAR DEGENERATION |
2010 |
|
RU2546008C2 |
| GENETIC MARKERS FOR PREDICTING SENSITIVITY TO THERAPY |
2014 |
- Dyube, Mari-Per
- Nisor, Erik Zh.
- Tardif, Zhan-Klod
- Upmanyu, Ruchi
|
RU2809215C2 |
| GENETIC MARKERS FOR PREDICTION OF SUSCEPTIBILITY TO THERAPY |
2014 |
- Dyube Mari-Per
- Nisor Erik Zh.
- Tardif Zhan-Klod
- Upmanyu Ruchi
|
RU2707533C2 |
| PREDICTION OF PROGRESSION OF AGE-RELATED MACULAR DYSTROPHY TO LATE STAGE BY MEANS OF POLYGENE INDICATOR |
2011 |
- Berens, Timoti, V.
- Grekhem, Robert, R.
|
RU2593954C2 |
| METHOD FOR TREATMENT WITH BUCINDOLOL BASED ON GENOTYPE DEFINITION |
2005 |
- Bristou Majkl
- Liggett Stefen B.
|
RU2389798C2 |
| GENETIC MARKERS FOR PREDICTING RESPONSE TO THERAPY BY RAISING HDL LEVEL OR IMITATING HDL AGENTS |
2015 |
- Dyube Mari-Per
- Tardif Zhan-Klod
|
RU2703192C2 |
| IDENTIFICATION, ASSESSMENT, AND THERAPY OF CANCERS WITH INNATE OR ACQUIRED RESISTANCE TO ALK INHIBITORS |
2011 |
- Mano Khiroyuki
- Choj Yang L.
- Soda Manabu
|
RU2589834C2 |
| METHODS FOR SELECTIVE TREATMENT OF ASTHMA USING IL-13 ANTAGONISTS |
2015 |
- Damask Amy
- Lewitzky Steven
- Rotte Michael Andreas
|
RU2694980C2 |
